A phase I trial targeting advanced or metastatic pancreatic cancer using a combination of standard chemotherapy and adoptively transferred nonengineered, multiantigen specific T cells in the first-line setting (TACTOPS).Brandon G. Smaglo, Ann M. Leen, Ayumi Watanabe et al.|Journal of Clinical Oncology|2020Cited by 15
Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 Stabilization and Chromatin CondensationLaure Maneix, André Catic, Polina Iakova et al.|Cancer Research Communications|2022Cited by 8